{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:23:27Z","timestamp":1746343407826},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T00:00:00Z","timestamp":1405036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00106-014-2890-9","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T15:09:12Z","timestamp":1404918552000},"page":"396-401","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lokale Medikamententherapie bei Innenohrschwerh\u00f6rigkeit"],"prefix":"10.1007","volume":"63","author":[{"given":"A.","family":"Liebau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Plontke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,11]]},"reference":[{"key":"2890_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00129492-200503000-00004","volume":"26","author":"Merchant","year":"2005","unstructured":"Merchant SN, Adams JC, Nadol JB Jr (2005) Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 26:151\u2013160","journal-title":"Otol Neurotol"},{"key":"2890_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0033-1349848","volume":"92","author":"Plontke","year":"2013","unstructured":"Plontke S (2013) Emergencies in sensory organs of the otorhinolaryngologic area. Laryngol Rhinol Otol 92:545\u2013560, quiz 561\u2013562","journal-title":"Laryngol Rhinol Otol"},{"key":"2890_CR3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MAO.0b013e318254ee04","volume":"33","author":"Garavello","year":"2012","unstructured":"Garavello W, Galluzzi F, Gaini RM, Zanetti D (2012) Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 33:724\u2013729","journal-title":"Otol Neurotol"},{"key":"2890_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1741-7015-8-76","volume":"8","author":"Nakagawa","year":"2010","unstructured":"Nakagawa T, Sakamoto T, Hiraumi H et al (2010) Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med 8:76","journal-title":"BMC Med"},{"key":"2890_CR5","first-page":"CD008080","volume":"Rev","author":"Plontke","year":"2009","unstructured":"Plontke SK, Caye-Thomasen P, Agrawal S, Mikulec T (2009) A systematic review and metaanalysis of intratympanic glucocorticosteroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev (Protocol) 4:CD008080; full review 2014 (under review)","journal-title":"Cochrane Database Syst"},{"key":"2890_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MAO.0b013e318254ee04","volume":"33","author":"Garavello","year":"2012","unstructured":"Garavello W, Galluzzi F, Gaini RM, Zanetti D (2012) Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 33:724\u2013729","journal-title":"Otol Neurotol"},{"key":"2890_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00129492-200501000-00013","volume":"26","author":"Merchant","year":"2005","unstructured":"Merchant SN, Adams JC, Nadol JB Jr (2005) Pathophysiology of Meniere\u2019s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74\u201381","journal-title":"Otol Neurotol"},{"key":"2890_CR8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/MLG.0b013e31817d01cd","volume":"118","author":"Salt","year":"2008","unstructured":"Salt AN, Gill RM, Plontke SK (2008) Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope 118:1793\u20131800","journal-title":"Laryngoscope"},{"key":"2890_CR9","first-page":"CD008514","volume":"6","author":"Phillips","year":"2011","unstructured":"Phillips JS, Westerberg B (2011) Intratympanic steroids for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev 6:CD008514","journal-title":"Cochrane Database Syst Rev"},{"key":"2890_CR10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/MAO.0b013e318263d35d","volume":"33","author":"Lambert","year":"2012","unstructured":"Lambert PR, Nguyen S, Maxwell KS et al (2012) A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol 33:1257\u20131265","journal-title":"Otol Neurotol"},{"key":"2890_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moo.0000136101.95662.aa","volume":"12","author":"Ruckenstein","year":"2004","unstructured":"Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426\u2013430","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2890_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000095897","volume":"11","author":"Van","year":"2006","unstructured":"Van Wijk F, Staecker H, Keithley E, Lefebvre PP (2006) Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 11:357\u2013365","journal-title":"Audiol Neurootol"},{"key":"2890_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0378-5955(98)00200-7","volume":"128","author":"Sha","year":"1999","unstructured":"Sha SH, Schacht J (1999) Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res 128:112\u2013118","journal-title":"Hear Res"},{"key":"2890_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","volume":"226","author":"Rybak","year":"2007","unstructured":"Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157\u2013167","journal-title":"Hear Res"},{"key":"2890_CR15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.addr.2008.08.001","volume":"60","author":"Swan","year":"2008","unstructured":"Swan EEL, Mescher MJ, Sewell WF et al (2008) Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 60:1583\u20131599","journal-title":"Adv Drug Deliv Rev"},{"key":"2890_CR16","unstructured":"Gilbey P, Khalil K, Zidan J (2011) Intratympanic steroid treatment for the prevention of inner ear toxicity associated with systemic treatment with cisplatin. ClinicalTrials.gov identifier NCT01285674. Zugegriffen: 23. Apr. 2014"},{"key":"2890_CR17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03655230410017111","volume":"552","author":"Sergi","year":"2004","unstructured":"Sergi B, Fetoni AR, Ferraresi A et al (2004) The role of antioxidants in protection from ototoxic drugs. Acta Otolaryngol Suppl 552:42\u201345","journal-title":"Acta Otolaryngol Suppl"},{"key":"2890_CR18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/00016480601110212","volume":"127","author":"Suckfuell","year":"2007","unstructured":"Suckfuell M, Canis M, Strieth S et al (2007) Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I\/II study. Acta Otolaryngol 127:938\u2013942","journal-title":"Acta Otolaryngol"},{"key":"2890_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1084713806296720","volume":"10","author":"Hochmair","year":"2006","unstructured":"Hochmair I, Nopp P, Jolly C et al (2006) MEDEL cochlear implants: state of the art and a glimpse into the future. Trends Amplif 10:201\u2013219","journal-title":"Trends Amplif"},{"key":"2890_CR20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/00016480310000755a","volume":"124","author":"Kiefer","year":"2004","unstructured":"Kiefer J, Gstoettner W, Baumgartner W et al (2004) Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 124:272\u2013280","journal-title":"Acta Otolaryngol"},{"key":"2890_CR21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","volume":"14","author":"Salt","year":"2009","unstructured":"Salt AN, Plontke SK (2009) Principles of local drug delivery to the inner ear. Audiol Neurootol 14:350\u2013360","journal-title":"Audiol Neurootol"},{"key":"2890_CR22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.heares.2005.12.001","volume":"212","author":"Hahn","year":"2006","unstructured":"Hahn H, Kammerer B, DiMauro A et al (2006) Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear Res 212:236\u2013244","journal-title":"Hear Res"},{"key":"2890_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAO.0b013e318161aaae","volume":"29","author":"Plontke","year":"2008","unstructured":"Plontke SK, Biegner T, Kammerer B et al (2008) Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 29:401\u2013406","journal-title":"Otol Neurotol"},{"key":"2890_CR24","first-page":"43","volume":"457","author":"Juhn","year":"1989","unstructured":"Juhn S, Hamaguchi Y, Goycoolea M (1989) Review of round window membrane permeability. Acta Otolaryngol Suppl 457:43\u201348","journal-title":"Acta Otolaryngol Suppl"},{"key":"2890_CR25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1359-6446(05)03574-9","volume":"10","author":"Salt","year":"2005","unstructured":"Salt AN, Plontke SK (2005) Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 10:1299\u20131306","journal-title":"Drug Discov Today"},{"key":"2890_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MAO.0b013e3181f6cb25","volume":"32","author":"Plontke","year":"2011","unstructured":"Plontke SK (2011) Evaluation of the round window niche before local drug delivery to the inner ear using a new mini-otoscope. Otol Neurotol 32:183\u2013185","journal-title":"Otol Neurotol"},{"key":"2890_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.heares.2011.11.012","volume":"283","author":"Salt","year":"2012","unstructured":"Salt AN, King EB, Hartsock JJ et al (2012) Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res 283:14\u201323","journal-title":"Hear Res"},{"key":"2890_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10162-012-0347-y","volume":"13","author":"Salt","year":"2012","unstructured":"Salt AN, Hartsock JJ, Gill RM, Piu F, Plontke SK (2012) Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal. J Assoc Res Otolaryngol 13:771\u2013783","journal-title":"J Assoc Res Otolaryngol"},{"key":"2890_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-5955(91)90150-8","volume":"56","author":"Salt","year":"1991","unstructured":"Salt AN, Ohyama K, Thalmann R (1991) Radial communication between the perilymphatic scalae of the cochlea. I. Estimation by tracer perfusion. Hear Res 56:29\u201336","journal-title":"Hear Res"},{"key":"2890_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.aud.0000233864.32183.81","volume":"27","author":"Rask-Andersen","year":"2006","unstructured":"Rask-Andersen H, Schrott-Fischer A, Pfaller K, Glueckert R (2006) Perilymph\/modiolar communication routes in the human cochlea. Ear Hear 27:457\u2013465","journal-title":"Ear Hear"},{"key":"2890_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.heares.2005.01.001","volume":"204","author":"Richardson","year":"2005","unstructured":"Richardson RT, O\u2019Leary S, Wise A et al (2005) A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear Res 204:37\u201347","journal-title":"Hear Res"},{"key":"2890_CR32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00129492-200606000-00021","volume":"27","author":"Hargunani","year":"2006","unstructured":"Hargunani CA, Kempton JB, DeGagne JM, Trune DR (2006) Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 27:564\u2013569","journal-title":"Otol Neurotol"},{"key":"2890_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(01)01738-4","volume":"303","author":"Saito","year":"2001","unstructured":"Saito T, Zhang ZJ, Tokuriki M et al (2001) Expression of p-glycoprotein is associated with that of multidrug resistance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig. Neurosci Lett 303:189\u2013192","journal-title":"Neurosci Lett"},{"key":"2890_CR34","first-page":"133","volume":"Abs","author":"Salt","year":"2014","unstructured":"Salt AN, Hartsock JJ, Gill R et al (2014) Manipulations of dexamethasone kinetics in perilymph. Assoc Res Otolaryngol Abs:133","journal-title":"Assoc Res Otolaryngol"},{"key":"2890_CR35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.apsb.2013.02.003","volume":"3","author":"Liu","year":"2013","unstructured":"Liu H, Hao J, Li K (2013) Current strategies for drug delivery to the inner ear. Acta Pharm Sin B 3:86\u201396","journal-title":"Acta Pharm Sin B"},{"key":"2890_CR36","first-page":"2014","volume":"Neurotol","author":"Plontke","year":"2014","unstructured":"Plontke SK, Glien A, Rahne T et al (2014) Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol: 2014 May 16 (Epub ahead of print)","journal-title":"Otol"},{"key":"2890_CR37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.mao.0000235310.72442.4e","volume":"27","author":"Plontke","year":"2006","unstructured":"Plontke SK, Zimmermann R, Zenner HP, L\u00f6wenheim H (2006) Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol Neurotol 27:912\u2013917","journal-title":"Otol Neurotol"},{"key":"2890_CR38","unstructured":"Kitahara T (1996) Effects of endolymphatic sac drainage with steroids for intractable M\u00e9ni\u00e8re\u2019s disease: a long-term follow-up and randomized controlled study. ClinicalTrials.gov identifier NCT00500474. Zugegriffen: 23. Apr. 2014"},{"key":"2890_CR39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MAO.0b013e318254501b","volume":"33","author":"Hahn","year":"2012","unstructured":"Hahn H, Salt AN, Biegnert T et al (2012) Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig. Otol Neurotol 33:660\u2013665","journal-title":"Otol Neurotol"},{"key":"2890_CR40","unstructured":"Wu CC, Hsu CJ (2006) Applying proton pump inhibitor to prevent and treat acute fluctuating hearing loss in patients with SLC26A4 mutation. ClinicalTrials.gov identifier NCT00789061. Zugegriffen: 23. Apr. 2014"},{"key":"2890_CR41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOO.0b013e32830e20db","volume":"16","author":"Borkholder","year":"2008","unstructured":"Borkholder DA (2008) State-of-the-art mechanisms of intracochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg 16:472\u2013477","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2890_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0378-5955(99)00115-X","volume":"136","author":"Stover","year":"1999","unstructured":"Stover T, Yagi M, Raphael Y (1999) Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 136:124\u2013130","journal-title":"Hear Res"},{"key":"2890_CR43","unstructured":"Baumgartner J, Baumgartner L (2013) Safety of autologous stem cell infusion for children with acquired hearing loss. ClinicalTrials.gov identifier NCT02038972. Zugegriffen: 23. Apr. 2014"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-014-2890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-014-2890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-014-2890-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:59:32Z","timestamp":1565625572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-014-2890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1007\/s00106-014-2890-9","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,11]]}}}